abcnews.go.com

abcnews.go.com
Share

abcnews.go.com

 •  October 6

The U.S. Food and Drug Administration says drug shortages are possible because of expected long-term power outages in Puerto Rico. According to the agency, factories in Puerto Rico make nearly 10 percent of the medicines used by Americans, plus numerous medical devices. FDA Commissioner Dr. Scott Gottlieb said in a statement Friday that the agency...

abcnews.go.com

 •  September 29

An effort by drug makers to block Maryland's first-in-the-nation law against pharmaceutical price gouging was denied by a federal judge on Friday. A group representing makers of generic prescription drugs sought to stop the law from taking effect this Sunday, calling it an "unconstitutional overreach" that will create market instability. U.S....

abcnews.go.com

 •  September 18

New Jersey Gov. Chris Christie says pharmaceutical companies have agreed to work on nonaddictive pain medications and additional treatments to deal with opioid addiction. The Republican governor made the announcement in Trenton on Monday, shortly after he convened a meeting of the White House opioid commission that he chairs. He also held a news...

abcnews.go.com

 •  September 7

Eli Lilly will slash its global workforce by nearly 9 percent as the drugmaker closes some research sites and pushes to trim fixed costs. The Indianapolis company said Thursday it will cut about 3,500 positions, mostly through a voluntary retirement program in the United States. The insulin and cancer treatment maker employed 41,240 people...

abcnews.go.com

 •  August 17

The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. The agency approved Pfizer Inc.'s Besponsa for patients with a type of advanced acute lymphoblastic leukemia. By then, life expectancy is low. "These patients have few treatments available and...

abcnews.go.com

 •  June 27

The Food and Drug Administration is taking steps to boost the number of generic prescription drugs in an effort to make medicines more affordable and to prevent price gouging. Copycat pills normally are much cheaper than original brand-name drugs. But in some cases, when a generic has no competition, companies have drastically increased prices. New...

abcnews.go.com

 •  June 22

U.S. regulators have approved a more convenient version of a blockbuster drug for treating three common blood cancers.The Roche Group's Rituxan, on the market for 20 years, is administered in a hospital or clinic through an intravenous drip that can take several hours.On Thursday, the Food and Drug Administration approved the Swiss drugmaker's new...

abcnews.go.com

 •  June 19

The Supreme Court says hundreds of out-state-residents can't sue drugmaker Bristol-Myers Squibb Co. in California state court over adverse reactions to the blood thinner Plavix. The justices ruled 8-1 Monday that there was not a strong enough connection between the claims against the drugmaker and the company's ties to the state. The ruling is a...

abcnews.go.com

 •  June 8

U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER. It's the first time the FDA has asked for the removal of an opioid painkiller. Endo had touted the new...

abcnews.go.com

 •  May 31

The Ohio Attorney General sued five drugmakers on Wednesday for their alleged role perpetrating the state's addictions epidemic, accusing the companies of intentionally misleading patients about the dangers of painkillers and promoting benefits of the drugs not backed by science. Attorney General Mike DeWine said the companies created a deadly mess...